Your browser doesn't support javascript.
loading
Clinically proven drug targets differentially expressed in the prefrontal cortex of schizophrenia patients.
Voisey, Joanne; Mehta, Divya; McLeay, Robert; Morris, Charles P; Wockner, Leesa F; Noble, Ernest P; Lawford, Bruce R; Young, Ross McD.
Affiliation
  • Voisey J; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia. Electronic address: j.voisey@qut.edu.au.
  • Mehta D; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
  • McLeay R; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
  • Morris CP; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
  • Wockner LF; Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
  • Noble EP; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA.
  • Lawford BR; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
  • Young RM; Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Brain Behav Immun ; 61: 259-265, 2017 Mar.
Article in En | MEDLINE | ID: mdl-27940260

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / Gene Expression / Prefrontal Cortex Limits: Humans Language: En Journal: Brain Behav Immun Journal subject: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / Gene Expression / Prefrontal Cortex Limits: Humans Language: En Journal: Brain Behav Immun Journal subject: ALERGIA E IMUNOLOGIA / CEREBRO / PSICOFISIOLOGIA Year: 2017 Type: Article